JP2003512441A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003512441A5 JP2003512441A5 JP2001532809A JP2001532809A JP2003512441A5 JP 2003512441 A5 JP2003512441 A5 JP 2003512441A5 JP 2001532809 A JP2001532809 A JP 2001532809A JP 2001532809 A JP2001532809 A JP 2001532809A JP 2003512441 A5 JP2003512441 A5 JP 2003512441A5
- Authority
- JP
- Japan
- Prior art keywords
- protein drug
- mucosa
- activity
- domain
- pseudomonas exotoxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16092399P | 1999-10-22 | 1999-10-22 | |
| US60/160,923 | 1999-10-22 | ||
| PCT/US2000/029080 WO2001030392A2 (en) | 1999-10-22 | 2000-10-18 | Delivery of proteins across polar epithelial cell layers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011254351A Division JP2012051939A (ja) | 1999-10-22 | 2011-11-21 | 極性上皮細胞層を横断するタンパク質の送達 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003512441A JP2003512441A (ja) | 2003-04-02 |
| JP2003512441A5 true JP2003512441A5 (cg-RX-API-DMAC7.html) | 2005-06-30 |
Family
ID=22579051
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001532809A Withdrawn JP2003512441A (ja) | 1999-10-22 | 2000-10-18 | 極性上皮細胞層を横断するタンパク質の送達 |
| JP2011254351A Pending JP2012051939A (ja) | 1999-10-22 | 2011-11-21 | 極性上皮細胞層を横断するタンパク質の送達 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011254351A Pending JP2012051939A (ja) | 1999-10-22 | 2011-11-21 | 極性上皮細胞層を横断するタンパク質の送達 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7824695B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1242122B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2003512441A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE444081T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU784657B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2389302C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60043070D1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001030392A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE307208T1 (de) * | 1997-07-11 | 2005-11-15 | Us Gov Health & Human Serv | Pseudomonas exotoxin-a-ähnliche chimerische immunogene |
| EP1242122B1 (en) | 1999-10-22 | 2009-09-30 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Delivery of proteins across polar epithelial cell layers |
| US7713737B2 (en) | 2004-10-04 | 2010-05-11 | Trinity Biosystems, Inc. | Methods and compositions for needleless delivery of macromolecules |
| US7666991B2 (en) | 2005-12-05 | 2010-02-23 | Trinity Biosystems, Inc. | Compositions for needleless delivery of antibodies |
| US20090148401A1 (en) * | 2005-12-05 | 2009-06-11 | Trinity Biosystems, Inc. | Methods and compositions for needleless delivery of binding partners |
| EP2010205A2 (en) * | 2006-03-16 | 2009-01-07 | Trinity Biosystems, Inc. | Methods for increasing the size of animals using needleless delivery constructs |
| US11246915B2 (en) | 2010-09-15 | 2022-02-15 | Applied Molecular Transport Inc. | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo |
| PL3762009T3 (pl) | 2018-03-08 | 2022-09-12 | Applied Molecular Transport Inc. | Pochodzące z toksyny konstrukty dostarczające do dostarczania doustnego |
| SG11202104734YA (en) | 2018-11-07 | 2021-06-29 | Applied Molecular Transport Inc | Cholix-derived carriers for oral delivery of heterologous payload |
| MX2022001975A (es) | 2019-08-16 | 2022-03-11 | Applied Molecular Transport Inc | Composiciones, formulaciones y produccion y purificacion de interleucinas. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL78775A (en) * | 1985-05-15 | 1992-06-21 | Biotech Australia Pty Ltd | Oral vaccines |
| EP0654040A1 (en) * | 1992-06-23 | 1995-05-24 | Interactive Biologics Associates | Pharmaceutical composition containing botulinum b complex |
| AU7694594A (en) * | 1993-09-06 | 1995-03-27 | Menarini Ricerche Sud S.P.A. | Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them |
| DK0759944T3 (da) | 1994-05-13 | 2001-11-26 | Biovation Ltd | Forbedringer af og relateret til peptidfremføring |
| US6426075B1 (en) * | 1996-11-06 | 2002-07-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Protease-activatable pseudomonas exotoxin A-like proproteins |
| US6086900A (en) * | 1997-03-26 | 2000-07-11 | Board Of Regents, The University Of Texas Systems | Methods and compositions for using membrane-penetrating proteins to carry materials across cell membranes |
| US20030054012A1 (en) | 2000-05-12 | 2003-03-20 | Fitzgerald David J. | Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response |
| ATE307208T1 (de) * | 1997-07-11 | 2005-11-15 | Us Gov Health & Human Serv | Pseudomonas exotoxin-a-ähnliche chimerische immunogene |
| US6472140B1 (en) * | 1997-09-05 | 2002-10-29 | The General Hospital Corporation | α-2- macroglobulin therapies and drug screening methods for Alzheimer's disease. |
| EP1224290B1 (en) | 1999-10-22 | 2006-06-28 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Disulfide conjugated cell toxins and methods of making and using them |
| EP1242122B1 (en) | 1999-10-22 | 2009-09-30 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Delivery of proteins across polar epithelial cell layers |
| DK1379550T3 (da) | 2000-12-21 | 2009-07-06 | Us Gov Health & Human Serv | Et kimært protein omfattende non-toxisk pseudomonas exotoxin A og en type IV pilin sekvenser |
-
2000
- 2000-10-18 EP EP00975326A patent/EP1242122B1/en not_active Expired - Lifetime
- 2000-10-18 AU AU13392/01A patent/AU784657B2/en not_active Ceased
- 2000-10-18 AT AT00975326T patent/ATE444081T1/de not_active IP Right Cessation
- 2000-10-18 DE DE60043070T patent/DE60043070D1/de not_active Expired - Lifetime
- 2000-10-18 CA CA2389302A patent/CA2389302C/en not_active Expired - Fee Related
- 2000-10-18 US US10/110,880 patent/US7824695B1/en not_active Expired - Fee Related
- 2000-10-18 JP JP2001532809A patent/JP2003512441A/ja not_active Withdrawn
- 2000-10-18 WO PCT/US2000/029080 patent/WO2001030392A2/en not_active Ceased
-
2011
- 2011-11-21 JP JP2011254351A patent/JP2012051939A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025041812A5 (cg-RX-API-DMAC7.html) | ||
| Sato et al. | Further studies on the site-specific protein modification by microbial transglutaminase | |
| JP2001523465A5 (cg-RX-API-DMAC7.html) | ||
| KR100484084B1 (ko) | 키메라성 폴리펩타이드, 이의 제조 방법 및 용도 | |
| JP3872105B2 (ja) | インスリン誘導体 | |
| CN1195551C (zh) | 控制细胞活性的新试剂 | |
| EP1472351B1 (en) | Amino acid sequences capable of facilitating penetration across a biological barrier | |
| Mita et al. | Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication. | |
| JP2010507391A (ja) | 組織傷害の修復におけるストロマ細胞由来因子1のプロテアーゼ耐性変異体 | |
| ATE169959T1 (de) | Anthrax-toxin-fusionsproteine und deren verwendungen | |
| JP2020508691A5 (cg-RX-API-DMAC7.html) | ||
| JPH0755151B2 (ja) | 選定蛋白質およびそれをコードする組替えdna分子 | |
| JP2002513556A5 (cg-RX-API-DMAC7.html) | ||
| KR20070073863A (ko) | 거대분자의 무침 전달을 위한 방법 및 조성물 | |
| JP2006149406A5 (cg-RX-API-DMAC7.html) | ||
| JP2005537032A5 (cg-RX-API-DMAC7.html) | ||
| JP2003507012A5 (cg-RX-API-DMAC7.html) | ||
| JP2006187292A5 (cg-RX-API-DMAC7.html) | ||
| JP2009536170A (ja) | 治療用の抗体標的指向サイトカイン | |
| CN117298254A (zh) | 用于口服递送生物活性货物的cholix毒素衍生的融合分子 | |
| ES2241040T3 (es) | Proteinas hibridas que forman heterodimeros. | |
| CA2389302A1 (en) | Delivery of proteins across polar epithelial cell layers | |
| JP2006515744A5 (cg-RX-API-DMAC7.html) | ||
| BR9713847A (pt) | Polipeptìdeo isolado codificado por um gene semelhante a lipase, composição, composição farmacêutica, fragmento antigênico, ácido nucleico isolado, vetor, célula recombinante, anticorpo, célula de hibridoma, processos para preparar um polipeptìdeo, para triar agonistas ou antagonistas de atividade llg, para a hidrólise enzimática de um éster de fosfatidilcolina, e para melhorar o perfil de lipìdeo no soro de um humano ou outro animal tendo um perfil de lipìdeo indesejável, e, camundongo transgênico. | |
| KR20250140108A (ko) | 호흡기 세포융합 바이러스 mRNA 백신 |